Takeda Pharmaceutical (TAK) EBT Margin Growth (3y) (2020 - 2026)
Takeda Pharmaceutical (TAK) EBT Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1,840.00 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -134.00 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1,686.00 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 12,811.00 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 5,487.00 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -225.00 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -15,283.00 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1,162.00 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 4,514.00 |
| 10 | Takeda Pharmaceutical | 169,609.19 | -6.60 Bn | 4.39 Bn | -1,948.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,948.00 |
| Dec 31, 2025 | 542.00 |
| Sep 30, 2025 | 1,911.00 |
| Jun 30, 2025 | 916.00 |
| Mar 31, 2025 | 626.00 |
| Dec 31, 2024 | 684.00 |
| Sep 30, 2024 | 1,828.00 |
| Jun 30, 2024 | -1,217.00 |
| Mar 31, 2024 | -2,151.00 |
| Dec 31, 2023 | 685.00 |
| Sep 30, 2023 | 2,692.00 |
| Jun 30, 2023 | -349.00 |
| Mar 31, 2023 | -1,514.00 |
| Sep 30, 2022 | 384.00 |
| Jun 30, 2022 | 1,480.00 |
| Mar 31, 2022 | -2.92 Mn |
| Dec 31, 2021 | -152.00 |
| Mar 31, 2021 | 3,462.00 |
| Dec 31, 2020 | 187.00 |